Share

Blood sugar monitoring device approved for kids

accreditation
iStock
US Food and Drug Administration approval of the Dexcom G4 Platinum Continuous Monitoring System has been expanded to include children with diabetes aged 2 years to 17 years, the agency said.

Previously approved for adults only, the device constantly monitors the user's blood sugar, checking for dangerously high or low levels, the FDA said in a news release. An estimated 25.8 million people in the United States including 215 000 under age 20 have diabetes.

The external device, known as a continuous glucose monitor, includes a small, narrow sensor that's inserted just under the skin. That combined with a blood glucose meter can help the user's doctor decide treatment options, such as the amount of insulin to prescribe, the FDA said.

Read: Diabetes: blood pressure monitored by cell phone

The device was evaluated in clinical studies involving 176 people ages 2 to 17. The FDA warned the device's "performance in paediatric subjects was not as accurate as the performance of the same device in adults." Nonetheless, the agency said the device is still "effective for tracking and trending to determine patterns in glucose levels", and for warning users that their blood sugar had risen too high or fallen too low.

The system is produced by Dexacom Inc., based in San Diego.

Read more:

Google lenses may replace finger jabs for diabetics

Insulin pump with blood sugar sensor may improve on injections

Glucose tattoo for diabetics

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE